Concurrent hyperfractionated chemoradiotherapy for head and neck squamous cell carcinoma: the prognostic impact of the overall treatment time and completion rates of chemotherapy

about

Concurrent hyperfractionated chemoradiotherapy for head and neck squamous cell carcinoma: the prognostic impact of the overall treatment time and completion rates of chemotherapy

Item

http://www.wikidata.org/entity/Q35991873

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Concurrent hyperfractionated c ...... mpletion rates of chemotherapy

@ast

Concurrent hyperfractionated c ...... mpletion rates of chemotherapy

@en

type

Item

label

Concurrent hyperfractionated c ...... mpletion rates of chemotherapy

@ast

Concurrent hyperfractionated c ...... mpletion rates of chemotherapy

@en

prefLabel

Concurrent hyperfractionated c ...... mpletion rates of chemotherapy

@ast

Concurrent hyperfractionated c ...... mpletion rates of chemotherapy

@en

P1476

Concurrent hyperfractionated c ...... mpletion rates of chemotherapy

@en

P2093

Gunji Nagatani

http://www.w3.org/2001/XMLSchema#string

Hajime Imada

http://www.w3.org/2001/XMLSchema#string

Hideaki Suzuki

http://www.w3.org/2001/XMLSchema#string

Katsuya Yahara

http://www.w3.org/2001/XMLSchema#string

Kyosuke Tomura

http://www.w3.org/2001/XMLSchema#string

Mai Sakagami

http://www.w3.org/2001/XMLSchema#string

Masami Fujii

http://www.w3.org/2001/XMLSchema#string

Takayuki Ohguri

http://www.w3.org/2001/XMLSchema#string

Yukunori Korogi

http://www.w3.org/2001/XMLSchema#string

P2860

A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.

Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity.

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: randomised, non-inferiority, open trial.

Radical radiotherapy with concurrent weekly cisplatin in loco-regionally advanced squamous cell carcinoma of the head and neck: a single-institution experience.

Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of th

Local control of T3 carcinomas after accelerated fractionation: a look at the "gap".

Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer.

An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer

P2888

s40064-015-1244-8

P304

446

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40064-015-1244-8

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281483397

http://www.w3.org/2001/XMLSchema#string

P6179

1032674863

http://www.w3.org/2001/XMLSchema#string

P698

26322252

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

4547968

http://www.w3.org/2001/XMLSchema#string